PRECISION OPTICS CORPORATION, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
PRECISION OPTICS CORPORATION, INC. (POCI) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $247.53 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-05-13
- PRECISION OPTICS CORPORATION, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $247.53K, a 58.26% decline year-over-year.
- PRECISION OPTICS CORPORATION, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-12-31 was $162.08K, a 41.74% decline year-over-year.
- PRECISION OPTICS CORPORATION, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $301.64K, a 101.95% increase year-over-year.
- PRECISION OPTICS CORPORATION, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-03-31 was $592.96K, a 129.64% increase year-over-year.
- PRECISION OPTICS CORPORATION, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $1.46M, a 52.16% increase from fiscal 2024.
- PRECISION OPTICS CORPORATION, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $959.78K, a 4.43% increase from fiscal 2023.
- PRECISION OPTICS CORPORATION, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $919.03K, a 2.63% increase from fiscal 2022.
- PRECISION OPTICS CORPORATION, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $895.49K, a 22.01% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-03-31 | $247.53K 10-Q · filed 2026-05-13 | $409.61K derived: sum of 2 quarters · filed 2026-05-13 | $711.25K derived: sum of 3 quarters · filed 2026-05-13 | |
| 2025-12-31 | $162.08K 10-Q · filed 2026-05-13 | $463.72K derived: sum of 2 quarters · filed 2026-05-13 | ||
| 2025-09-30 | $301.64K 10-Q · filed 2026-05-13 | |||
| 2025-06-30 | $1.46M 10-K · filed 2025-09-29 | |||
| 2025-03-31 | $592.96K 10-Q · filed 2026-05-13 | $871.17K derived: sum of 2 quarters · filed 2026-05-13 | $1.02M derived: sum of 3 quarters · filed 2026-05-13 | |
| 2024-12-31 | $278.21K 10-Q · filed 2026-05-13 | $427.57K derived: sum of 2 quarters · filed 2026-05-13 | ||
| 2024-09-30 | $149.36K 10-Q · filed 2026-05-13 | |||
| 2024-06-30 | $959.78K 10-K · filed 2025-09-29 | |||
| 2024-03-31 | $258.21K 10-Q · filed 2025-05-15 | $640.64K derived: sum of 2 quarters · filed 2025-05-15 | $749.39K derived: sum of 3 quarters · filed 2025-05-15 | |
| 2023-12-31 | $382.43K 10-Q · filed 2025-05-15 | $491.18K derived: sum of 2 quarters · filed 2025-05-15 | ||
| 2023-09-30 | $108.75K 10-Q · filed 2025-05-15 | |||
| 2023-06-30 | $919.03K 10-K · filed 2024-09-30 | |||
| 2023-03-31 | $450.01K 10-Q · filed 2024-05-15 | $694.80K derived: sum of 2 quarters · filed 2024-05-15 | $769.79K derived: sum of 3 quarters · filed 2024-05-15 | |
| 2022-12-31 | $244.79K 10-Q · filed 2024-05-15 | $319.78K derived: sum of 2 quarters · filed 2024-05-15 | ||
| 2022-09-30 | $74.99K 10-Q · filed 2024-05-15 | |||
| 2022-06-30 | $895.49K 10-K · filed 2023-09-28 | |||
| 2022-03-31 | $231.12K 10-Q · filed 2023-05-15 | $561.57K derived: sum of 2 quarters · filed 2023-05-15 | $721.64K derived: sum of 3 quarters · filed 2023-05-15 | |
| 2021-12-31 | $330.45K 10-Q · filed 2023-05-15 | $490.52K derived: sum of 2 quarters · filed 2023-05-15 | ||
| 2021-09-30 | $160.07K 10-Q · filed 2023-05-15 | |||
| 2021-06-30 | $733.93K 10-K · filed 2022-09-27 | |||
| 2021-03-31 | $86.03K 10-Q · filed 2022-05-16 | $243.11K derived: sum of 2 quarters · filed 2022-05-16 | $314.25K derived: sum of 3 quarters · filed 2022-05-16 | |
| 2020-12-31 | $157.08K 10-Q · filed 2022-05-16 | $228.22K derived: sum of 2 quarters · filed 2022-05-16 | ||
| 2020-09-30 | $71.15K 10-Q · filed 2022-05-16 | |||
| 2020-06-30 | $502.35K 10-K · filed 2021-09-28 | |||
| 2020-03-31 | $75.57K 10-Q · filed 2021-05-13 | $350.27K derived: sum of 2 quarters · filed 2021-05-13 | $426.78K derived: sum of 3 quarters · filed 2021-05-13 | |
| 2019-12-31 | $274.71K 10-Q · filed 2021-05-13 | $351.21K derived: sum of 2 quarters · filed 2021-05-13 | ||
| 2019-09-30 | $76.50K 10-Q · filed 2021-05-13 | |||
| 2019-06-30 | $263.33K 10-K · filed 2020-09-24 | |||
| 2019-03-31 | $2.89K 10-Q · filed 2019-05-15 | $13.12K derived: sum of 2 quarters · filed 2019-05-15 | $356.10K derived: sum of 3 quarters · filed 2019-05-15 | |
| 2018-12-31 | $10.23K 10-Q · filed 2019-05-15 | $353.21K derived: sum of 2 quarters · filed 2019-05-15 | ||
| 2018-09-30 | $342.98K 10-Q · filed 2019-05-15 | |||
| 2018-06-30 | $52.34K 10-K · filed 2019-09-26 | |||
| 2018-03-31 | $8.97K 10-Q · filed 2019-05-15 | $15.95K derived: sum of 2 quarters · filed 2019-05-15 | $42.00K derived: sum of 3 quarters · filed 2019-05-15 | |
| 2017-12-31 | $6.97K 10-Q · filed 2019-05-15 | $33.03K derived: sum of 2 quarters · filed 2019-05-15 | ||
| 2017-09-30 | $26.06K 10-Q · filed 2019-05-15 | |||
| 2017-06-30 | $201.61K 10-K · filed 2018-09-27 | |||
| 2016-06-30 | $241.39K 10-K · filed 2017-09-28 | |||
| 2015-06-30 | $125.67K 10-K · filed 2016-09-28 | |||
| 2014-06-30 | $141.03K 10-K · filed 2015-10-13 | |||
| 2013-06-30 | $108.42K 10-K · filed 2014-09-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |